BRADLEY PHARMACEUTICALS INC·4

Apr 8, 3:36 PM ET

GLASSMAN DANIEL 4

4 · BRADLEY PHARMACEUTICALS INC · Filed Apr 8, 2005

Insider Transaction Report

Form 4
Period: 2005-03-17
GLASSMAN DANIEL
DirectorChairman, Pres. & CEO10% Owner
Transactions
  • Discretionary Transaction

    Common Stock

    2005-03-17$10.20/sh+22$22411,109 total(indirect: By 401(k))
Holdings
  • Stock Options (Right to buy)

    Exercise: $2.17From: 2001-02-23Exp: 2006-02-22Common Stock (25,000 underlying)
    25,000
  • Class B Common Stock

    (indirect: By Spouse)
    57,370
  • Common Stock

    (indirect: By Spouse)
    13,880
  • Common Stock

    449,090
  • Common Stock

    (indirect: By DLD Partners)
    8,460
  • Common Stock

    (indirect: By Foundation)
    14,000
  • Stock Options (Right to buy)

    Exercise: $1.41From: 2001-09-12Exp: 2005-09-11Common Stock (18,000 underlying)
    18,000
  • Stock Options (Right to buy)

    Exercise: $10.58From: 2003-07-09Exp: 2006-07-08Common Stock (12,554 underlying)
    12,554
  • Common Stock

    (indirect: By 401(k))
    3,030
  • Class B Common Stock

    (indirect: By Partnership)
    9,733
  • Class B Common Stock

    325,366
  • Stock Options (Right to buy)

    Exercise: $1.44From: 2000-12-05Exp: 2005-12-04Common Stock (341,589 underlying)
    341,589
  • Stock Options (Right to buy)

    Exercise: $13.13From: 2003-03-22Exp: 2007-03-21Common Stock (315,000 underlying)
    315,000
  • Common Stock

    (indirect: By IRA)
    11,500

Documents

1 file
  • 4
    doc.xmlPrimary

    PRIMARY DOCUMENT